[go: up one dir, main page]

AU1888900A - A novel formulation of n-(4-nitro-2-phenoxyphenyl)methanesulfonamide - Google Patents

A novel formulation of n-(4-nitro-2-phenoxyphenyl)methanesulfonamide

Info

Publication number
AU1888900A
AU1888900A AU18889/00A AU1888900A AU1888900A AU 1888900 A AU1888900 A AU 1888900A AU 18889/00 A AU18889/00 A AU 18889/00A AU 1888900 A AU1888900 A AU 1888900A AU 1888900 A AU1888900 A AU 1888900A
Authority
AU
Australia
Prior art keywords
phenoxyphenyl
methanesulfonamide
nitro
novel formulation
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU18889/00A
Inventor
Shashikant Prabhudas Kurani
Dinesh Shantilal Patel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU1888900A publication Critical patent/AU1888900A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU18889/00A 1999-05-31 1999-09-14 A novel formulation of n-(4-nitro-2-phenoxyphenyl)methanesulfonamide Abandoned AU1888900A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN406/BOM/99 1999-05-31
IN406BO1999 1999-05-31
PCT/IN1999/000047 WO2000072884A1 (en) 1999-05-31 1999-09-14 A novel formulation of n-(4-nitro-2-phenoxyphenyl)methanesulfonamide

Publications (1)

Publication Number Publication Date
AU1888900A true AU1888900A (en) 2000-12-18

Family

ID=11079986

Family Applications (1)

Application Number Title Priority Date Filing Date
AU18889/00A Abandoned AU1888900A (en) 1999-05-31 1999-09-14 A novel formulation of n-(4-nitro-2-phenoxyphenyl)methanesulfonamide

Country Status (3)

Country Link
AU (1) AU1888900A (en)
RU (1) RU2238086C2 (en)
WO (1) WO2000072884A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100346785C (en) * 2001-10-25 2007-11-07 迪内希尚蒂拉尔·帕特尔 New formulations of selective cyclooxygenase Ⅱ inhibitors
WO2003035063A1 (en) * 2001-10-25 2003-05-01 Dinesh Shantilal Patel Novel preparation of selective cyclooxygenase ii inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837735A (en) * 1994-10-05 1998-11-17 Helsinn Healthcare S.A. Antiinflammatory agent for external use
HUP9601442A3 (en) * 1995-07-25 1999-03-29 Panacea Biotec Ltd Nes antinflammatory and analgetic pharmaceutical compositions, containing nimesulid for transdermal use, and process for producing them
IT1291278B1 (en) * 1996-07-05 1999-01-07 Errekappa Euroterapici S P A NIMESULIDE-BASED PHARMACEUTICAL PREPARATION FOR TOPICAL USE
RU2141845C1 (en) * 1996-07-24 1999-11-27 Панацея Биотек Лтд. Pharmaceutical composition of analgetic agent and method of its preparing
IT1289973B1 (en) * 1997-02-25 1998-10-19 Helsinn Healthcare Sa GELIFIED NIMESULIDE SYSTEMS FOR TOPICAL USE
WO1999041233A1 (en) * 1998-02-17 1999-08-19 Micio Pharma Chemical Aktiengesellschaft A watersoluble nimesulide adduct also for injectable use

Also Published As

Publication number Publication date
RU2238086C2 (en) 2004-10-20
WO2000072884A1 (en) 2000-12-07

Similar Documents

Publication Publication Date Title
AUPP970099A0 (en) Concrete formulation
AU1440901A (en) Fluorochemical sulfonamide surfactants
AU8551198A (en) Agrochemical formulation
AU3243300A (en) Multiparticulate formulation
AU3364900A (en) Microelectromechanical rotary structures
AU2001241236A1 (en) A therapeutic agent of osteoporosis comprising an active ingredient of quercetinderivatives
AU5266900A (en) Apparatus for fabrication of miniature structures
SI1218374T1 (en) Pharmaceutically active sulfonamide derivatives
EP1222192B8 (en) Hexahydrofuro¬2,3-b furan-3-yl-n- 3-¬(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino -1-benzyl-2-hydroxypropyl carbamate as retroviral protease inhibitor
AUPQ441699A0 (en) Pour-on formulations
AU5235599A (en) N-substituted sulfonamide derivatives
AU8860898A (en) Substituted n-aryl-n-thioxocarbonyl sulfonamides as herbicides
AU4328800A (en) Pharmaceutical formulation
AU2080199A (en) New pharmaceutically active compounds
AU5416000A (en) Sulfonamide substituted benzylamine derivatives and their use as medicaments
AU2320500A (en) Sulfonamide derivatives having cyclic structures
AU1888900A (en) A novel formulation of n-(4-nitro-2-phenoxyphenyl)methanesulfonamide
AU6036100A (en) New pharmaceutically active compounds
AU3196300A (en) Carbocyclic sulfonamide derivatives
AUPP105597A0 (en) Solvent/surfactant insecticidal pour-on formulation
AU7450300A (en) Sulfonamide derivatives
AU3839900A (en) Pharmaceutical formulation
AU6271098A (en) Hiv integrase inhibitors
AU5182099A (en) Pharmaceutical formulation
AU1388501A (en) Pharmaceutical formulation

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase